A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
Clinical trial NCT02747004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02747004
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-14
- Primary completion
- 2018-06-15
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.